This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Improving Measurement Of Parents' Understanding Of Research Permission

This study is currently recruiting participants.
See Contacts and Locations
Verified April 2017 by Carl D'Angio, University of Rochester
Information provided by (Responsible Party):
Carl D'Angio, University of Rochester Identifier:
First received: October 4, 2012
Last updated: April 27, 2017
Last verified: April 2017
Well-informed potential subjects are presumably better able to make autonomous decisions about the risks and benefits of participating in a research study than those in possession of less information. In actuality, prior research into consent understanding suggests that longer forms offering exhaustive information may inhibit rather than promote understanding. Moreover, technical wording in tools used to measure parent understanding of research permission may also lead to inhibition of understanding. This study will test the hypothesis that, among parents of potential subjects for greater-than-minimal-risk research, two modified and simplified subset of questions from the Deaconess Informed Consent Comprehension Test (DICCT), one oral and open-ended and one written and multiple choice, will increase subject understanding of the nature and risks of the research. The study will enroll the parents of 40 potential neonatal research subjects with an interim analysis of data at 20 subjects. Subjects will review a sham research permission form and will be randomized 1:1 to complete one of the two modified comprehension tests in addition to the DICCT (gold-standard) test. Parents will be given an open-ended survey after the tests in order to qualitatively describe their opinions of each test. A subset of parents who have received the written form will also undergo a cognitive interview about the form. A similar subset will also be given an open-ended survey about a proposed permission form cover sheet. The primary outcome will be the correlation of scores between the DICCT and modified comprehension tests, following the sham informed consent process.

Condition Intervention
Improve Parent Understanding of Research Permission Other: Coversheet to Informed Consent

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Health Services Research

Further study details as provided by Carl D'Angio, University of Rochester:

Primary Outcome Measures:
  • DICCT Questionnaire [ Time Frame: Within 2 weeks after being approached for participation. ]

    Score on the post-permission DICCT questionnaire. The DICCT is scored on a 28 point scale, with each of 14 parameters being scored as 0 = incorrect, 1 = partially correct, 2 = correct. The DICCT, in addition to being previously validated, has other advantages. It contains questions that are not directly addressed in the cover sheet, but addressed in the full permission form, such as compensation for injury. These items will serve as valuable internal controls. The DICCT is easily adaptable to written answers, which makes it ideal for further modification in future studies.

    The DICCT will be administered during a structured interview, without a time limit. The parent will be allowed to refer to the permission form to answer the questions.

Estimated Enrollment: 40
Study Start Date: March 2012
Estimated Study Completion Date: January 2019
Estimated Primary Completion Date: December 31, 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Coversheet to Informed Consent
Coversheet attached to Informed Consent.
Other: Coversheet to Informed Consent
The intervention is a one page cover sheet to be affixed to the front of the standard permission form for the trial for which permission is being sought (attached to application). The form will identify the study as research and contain sections that include investigator contact information, the purpose of the study, a brief description of the study procedures, the alternatives, the voluntary nature, the risks, the potential benefits, a discussion of privacy and confidentiality, the costs and the payments. Each topic will also contain a reference to the page in the consent containing the full description of the topic. The form is designed to have a reading level no higher than 6th to 8th grade. Parents will also receive the full permission form, and all required signatures will still be collected on the permission form.
No Intervention: No Coversheet
Standard, full permission form, without the coversheet.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Parents of potential subjects eligible for a NICHD Neonatal Research Network (NRN) interventional trial ("Hydrocortisone/Extubation") or greater-than-minimal risk observational trial ("PROP")
  • Permission being sought for a qualifying study
  • English speaking

Exclusion Criteria:

  • Permission has not been previously sought for another qualifying study
  • Illiteracy (unable to read simple forms)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01704560

United States, New York
Women and Children's Hospital of Buffalo Recruiting
Buffalo, New York, United States, 14222
Contact: Michael G Sacilowski, MAT, CCRC    716-878-7140   
Principal Investigator: Satyan Lakshminrusimha, MD         
Sub-Investigator: Anne Marie Reynolds, MPH, MD         
Ann Marie Scorsone Enrolling by invitation
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
Principal Investigator: Carl T D'Angio, MD University of Rochester
  More Information

Responsible Party: Carl D'Angio, Professor, University of Rochester Identifier: NCT01704560     History of Changes
Other Study ID Numbers: 39377
Study First Received: October 4, 2012
Last Updated: April 27, 2017 processed this record on September 21, 2017